Regeneron Pharmaceuticals, Inc. 13D and 13G filings for Decibel Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-09-27 4:05 pm Sale |
2023-08-08 | 13D | Decibel Therapeutics, Inc. DBTX |
REGENERON PHARMACEUTICALS INC. REGN |
100 100.000% |
-2,097,214 (-100.00%) |
Filing |
| 2023-08-18 5:16 pm Unchanged |
2023-08-08 | 13D | Decibel Therapeutics, Inc. DBTX |
REGENERON PHARMACEUTICALS INC. REGN |
2,097,314 8.300% |
0 (Unchanged) |
Filing |
| 2022-02-11 4:05 pm Purchase |
2021-12-31 | 13G | Decibel Therapeutics, Inc. DBTX |
REGENERON PHARMACEUTICALS INC. REGN |
2,097,314 8.420% |
2,097,314 (New Position) |
Filing |